Great Posts, Kwaidan, much better to spend time discussing POH s pain portfolio which is shaping up tp be better than KING PHARMACEUTICALs that recently sold for $3.5 BILLION.
So POH's pain portfolio could be worth over $4 per share after the OXY trial planned for 2H this year.
That is the sort of interesting debate traders and investors like.
Even the analysts are starting to notice the value lurking in this company.
PoS
it`s the balance sheet stupid, page-28
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 90794613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 54998583 | 13 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |